Applications are welcome for one further project within our CDT to commence in October 2021. Please visit our webpage for up to date information regarding the EPSRC Centre for Doctoral Training (CDT) in Molecular Sciences for Medicine (MoSMed) and all available studentship opportunities.
Applications are invited from suitably qualified graduates for fully funded 4-year PhD studentships in the area of Molecular Sciences for Medicine (MosMed) and will focus on unmet medical needs, such as:
The CDT in Molecular Sciences for Medicine (MoSMed) is a joint venture between Newcastle and Durham Universities. It will train the next generation of researchers at the interface of molecular and medical sciences, business skills, innovation and entrepreneurship.
Research projects will focus on the development of new molecular approaches to the treatment of disease, centered around three research themes:
Find out more here.
Candidates should have a good Master’s level degree in a subject aligned with your chosen project; typically this will be synthetic chemistry, medicinal chemistry, theoretical chemistry, biochemistry, molecular biology, structural biology, cell biology, molecular modelling, computer science, and biophysics. First class Bachelor degrees plus relevant experience will also be considered. Please note that due to pre-existing funding commitments associated with this project, applications are open to UK Home students only.
Please find below the details of the additional project available to commence in October 2021.
For general CDT enquiries, please email: firstname.lastname@example.org
|No Live Listings|
|Code||Project Title||Lead Supervisor||Institution|
|21_01||Development of multi-functional cyclic peptide probes||Akane Kamuwara||Newcastle|
|21_02||Sleeping superbugs: exploring key proteins in C. difficile spore formation||Paula Salgado||Newcastle|
|21_03||Small molecule tools to target glucose metabolism in Nonalcoholic fatty liver disease||Celine Cano||Newcastle|
|21_04||Novel approaches to targeted protein degradation||Ian Hardcastle||Newcastle|
|21_05||The design, synthesis and application of covalent fragment||Mike Waring||Newcastle|
|21_06||Activity_based probes as chemical tool to identify protease involved in mRNA splicing||Chiara Maniaci||Newcastle|
|21_07||Generation of DNA aptamers to detect and differentiate between latent and active tuberculosis||Neil Keegan||Newcastle|
|21_08||Improving the outcome of organ transplantation by analysis of chemokine modifications in ischaemia reperfusion injury||Simi Ali||Newcastle|
|21_09||Harnessing tuberculosis toxins to manipulate bacterial growth||Tim Blower||Durham|
|21_10||Polymer-based biosensing platforms for bacterial proteins||Clare Mahon||Durham|
|21_11||Delivering Mechanistic Understanding and Novel Approaches to Native Chemical Ligation||AnnMarie O'Donoghue||Durham|
|21_12||PROTAC enabled avenues for nasopharyngeal carcinoma(NPC) immunotherapy||Steven Cobb||Durham|
|21_13||New Detection technologies for emerging infectious diseases||Ehmke Pohl||Durham|
The information you submit to this university will only be used by them to deal with your enquiry. For more information on how we use your data, please read our privacy statement